David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund
General Catalyst’s Customer Value Fund doesn’t make equity investments. It’s providing $1 billion for IM8, known for its longevity vitamin drink.
General Catalyst’s Customer Value Fund doesn’t make equity investments. It’s providing $1 billion for IM8, known for its longevity vitamin drink.
The company is raising at least $75 million, led by Robot, with significant participation from USV and other prominent investors.
The company is raising at least $75 million, led by Robot, with significant participation from USV and other prominent investors.
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a…
Fizz has expanded its lawsuit against rival Sidechat, alleging that a Maveron VC shared its confidential information obtained during a fundraising meeting with the competing startup.
In this week’s episode of Build Mode, Isabelle Johannessen talks with Precursor Ventures’ Charles Hudson about the headwinds facing early-stage founders today and the most common mistakes founders should avoid in order to get funded.
A new $20 billion valuation would be a giant step up from the $10 billion valuation it reached in October.
The Paris-based ElevenLabs competitor, just announced a hefty seed extension round.
Nilekani remains Fundamentum’s anchor investor as the firm expands its leadership team and targets AI and fintech startups in India.
Paradigm, the VC firm founded in 2018 to back crypto startups, raised a $1.2 billion Fund III.